Trial intelligence / Profile preview

Dydrogesterone versus oral contraceptive pills for small endometrial polyps

IRCT20260423069139N1Phase 3Recruiting

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial in endometrial polyp comparing Dydrogesterone with Oral contraceptive pill control (2 arms). Primary endpoint: Endometrial polyp size. Started Jun 2026; status: recruiting.

02

Drugs

dydrogesteroneethinylestradiol + levonorgestrel
03

Conditions

endometrial polyp

Beyond the preview

Go deeper on IRCT20260423069139N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20260423069139N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call